
A Mark Biotech Private Limited
Founded in 2005 and headquartered in Bihar, India.
Founded in 2005 and headquartered in Bihar, India.
Patna, Bihar, India
+91-XXXXXXXXXX
U24230BR2005PTC011570
011570
Private Limited Indian Non-Government Company
24 Aug 2005
30 Sep 2011
31 Mar 2011
Unlisted
Roc Patna
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arjun Keshri ![]() | Managing Director | 24-Aug-2005 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajiv Keshri ![]() | Director | 24-Aug-2005 | Current |
Enhance accessibility to A Mark Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to A Mark Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Arjun Keshri is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with A Mark Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of A Mark Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A Mark Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A Mark Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2011 as per latest MCA records.
A Mark Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Patna.
Arjun Kumar Keshri was appointed as a Managing Director was appointed as a Managing Director on 24 Aug 2005 & has been associated with this company since 19 years 8 months .
Rajiv Keshri was appointed as a Director was appointed as a Director on 24 Aug 2005 & has been associated with this company since 19 years 8 months .
A Mark Biotech Private Limited was registered on 24 Aug 2005 with Roc Patna & aged 19 years 8 months as per MCA records.
A Mark Biotech Private Limited was incorporated on 24 Aug 2005.
The authorized share capital of A Mark Biotech Private Limited is ₹ 2.00 M and paid-up capital is ₹ 0.15 M.
Currently 2 directors are associated with A Mark Biotech Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of A Mark Biotech Private Limited is S. Chatterjee Group H/No.-402/381 Circle No.-23 Govind Mitra Road, India, Patna, Bihar, 800004.
The corporate identification number (CIN) of A Mark Biotech Private Limited is U24230BR2005PTC011570 and the company number is 011570 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for A Mark Biotech Private Limited was filed with the ROC on 31 Mar 2011.
Search company & director profiles for free and gain access to critical business data.